Financial terms of the deal were not disclosed. The sale relates to Aetna’s proposed acquisition of Coventry Health Care.
In August, Aetna said it would buy Coventry for $5.7 billion in cash and stock, and including Coventry’s debt, the transaction is estimated to be worth $7.3 billion. Coventry currently has a Medicaid plan in Missouri, and Missouri’s Medicaid contracts would not allow Aetna to control both Coventry’s Medicaid plan as well as Missouri Care.
Missouri Care covers 100,000 people across the state, while Coventry’s Medicaid plan covers more than 250,000 Missourians. The sale of Missouri Care is pending regulatory approval, as is Aetna’s acquisition of Coventry. Aetna’s expects the Coventry acquisition will be finalized in the middle of this year.
More Articles on Aetna:
20-Plus Ohio Hospitals, Health Systems Join Aetna’s Medicare Advantage Network
Aetna, Optimus HealthCare in New Jersey Start ACO
New Jersey’s AtlantiCare, Aetna Ink Deal
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
